ROBERT F. KENNEDY JR.: The future of medicine should be built in America
Health and Human Services Secretary Robert F. Kennedy Jr. is leading an effort to reshore pharmaceutical manufacturing and accelerate clinical research. The initiative aims to counter China's growing lead in early-stage clinical trials. The White House has expressed support for reducing reliance on foreign drug supply chains.
What changed
Secretary Kennedy launched Operation TrialBlazer to speed up early drug research in the US.
Live updates
-
HHS Secretary Kennedy Pushes for US-Led Medical Innovation
confidence 95%Health and Human Services Secretary Robert F. Kennedy Jr. is leading an effort to reshore pharmaceutical manufacturing and accelerate clinical research. The initiative aims to counter China's growing lead in early-stage clinical trials. The White House has expressed support for reducing reliance on foreign drug supply chains.
What's confirmed:
- HHS Secretary Robert F. Kennedy Jr. stated that the future of medicine should be built in America.
- China currently conducts more early-stage clinical trials than the United States.
- Chinese companies accounted for nearly half of global pharmaceutical licensing deal activity in 2025.
- The FDA is leading a pilot initiative called Operation TrialBlazer to speed up early drug research.
- The FDA estimates that the new multi-agency effort could reduce development timelines by 6 to 12 months.
Still unconfirmed:
- China is quietly taking control of US medicine.
- The US leads in biotech quality and commercial reach.
- Some researchers are looking abroad due to Trump cutting science budgets.